Adage Capital Partners Gp, L.L.C. Standard Biotools Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $1.45 Million - $2.45 Million	-400,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $2.2 Million - $2.96 Million	400,000 New	400,000 $2.64 Million
Q2 2018 Aug 14, 2018	SELL	$4.86 - $6.24 $91,008 - $116,850	-18,726 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$5.75 - $7.97 $6.7 Million - $9.29 Million	-1,165,407 Reduced 98.42%	18,726 $109,000
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $2.89 Million - $4.17 Million	-647,119 Reduced 35.34%	1,184,133 $6.98 Million
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $6.5 Million - $10.1 Million	1,831,252	1,831,252 $9.23 Million

143

274M

6.7K

48.7K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $95.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.